Showing 141 - 160 results of 49,942 for search '(((( via ((teer decrease) OR (a decrease)) ) OR ( b large increases ))) OR ( i large increases ))', query time: 0.51s Refine Results
  1. 141

    Longer Cations Increase Energetic Disorder in Excitonic 2D Hybrid Perovskites by Daniel B. Straus (1234383)

    Published 2019
    “…These substitutions increase the length of the cation but leave the cross-sectional area unchanged, resulting in structurally similar PbI<sub>4</sub><sup>2–</sup> frameworks with increasing interlayer spacing. …”
  2. 142

    Longer Cations Increase Energetic Disorder in Excitonic 2D Hybrid Perovskites by Daniel B. Straus (1234383)

    Published 2019
    “…These substitutions increase the length of the cation but leave the cross-sectional area unchanged, resulting in structurally similar PbI<sub>4</sub><sup>2–</sup> frameworks with increasing interlayer spacing. …”
  3. 143

    Longer Cations Increase Energetic Disorder in Excitonic 2D Hybrid Perovskites by Daniel B. Straus (1234383)

    Published 2019
    “…These substitutions increase the length of the cation but leave the cross-sectional area unchanged, resulting in structurally similar PbI<sub>4</sub><sup>2–</sup> frameworks with increasing interlayer spacing. …”
  4. 144

    Longer Cations Increase Energetic Disorder in Excitonic 2D Hybrid Perovskites by Daniel B. Straus (1234383)

    Published 2019
    “…These substitutions increase the length of the cation but leave the cross-sectional area unchanged, resulting in structurally similar PbI<sub>4</sub><sup>2–</sup> frameworks with increasing interlayer spacing. …”
  5. 145

    Longer Cations Increase Energetic Disorder in Excitonic 2D Hybrid Perovskites by Daniel B. Straus (1234383)

    Published 2019
    “…These substitutions increase the length of the cation but leave the cross-sectional area unchanged, resulting in structurally similar PbI<sub>4</sub><sup>2–</sup> frameworks with increasing interlayer spacing. …”
  6. 146
  7. 147
  8. 148

    <b>An E115A missense variant in </b><b><i>CERS2</i></b><b> is associated with</b><b>increased sleeping energy expenditure and hepatic insulin resistance in American Indians</b> by Sascha Heinitz (8742357)

    Published 2024
    “…Association analysis of 10,084 genetic variants within 28 genes involved in sphingolipid pathways identified a missense variant (rs267738, A>C, E115A) in exon 4 of <i>CERS2</i> that was associated with higher sleeping EE (+116 kcal/day) and increased rates of endogenous glucose production during basal (+5%) and insulin-stimulated (+43%) conditions, both indicators of hepatic insulin resistance. …”
  9. 149
  10. 150
  11. 151

    Species richness (<i>SR</i>, upper panels) and Shannon’s entropy (<i>SE</i>, lower panels) vs. the rate in which new species are trying to invade the community, <i>νN</i>. by Immanuel Meyer (12306666)

    Published 2022
    “…When the number of temporal niches is large, as in the <i>Q</i> = 30 case in panels (c) and (f), an increase of <i>νN</i> leads to an increase in the number of species, their different response buffers the effect of environmental variations and the results converge to the predictions of the neutral model (cyan dashed line). …”
  12. 152

    Deletion of murine <i>Rhoh</i> leads to de-repression of <i>Bcl-6</i> via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphoma by Hiroto Horiguchi (3215001)

    Published 2022
    “…RHOH was initially identified as a translocation partner with BCL-6 in non-Hodgkin lymphoma (NHL), and aberrant somatic hypermutation (SHM) in the 5ʹ untranslated region of the RHOH gene has also been detected in Diffuse Large B-Cell Lymphoma (DLBCL). …”
  13. 153

    US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma by Matthew Matasar (16946467)

    Published 2023
    “…<p>We evaluated the pharmacoeconomic value of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) in previously untreated diffuse large B-cell lymphoma (DLBCL) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).…”
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158

    AI-Enhanced Methods in Autonomous Systems: Large Language Models, DL Techniques, and Optimization Algorithms by I. de Zarza (17378452)

    Published 2024
    “…<p dir="ltr">Presentation for PhD thesis:</p><p dir="ltr">AI-Enhanced Methods in Autonomous Systems: Large Language Models, DL Techniques, and Optimization Algorithms https://doi.org/10.4995/Thesis/10251/202201</p><p dir="ltr">Abstract:</p><p dir="ltr">The proliferation of autonomous systems, and their increasing integration with day-to-day human life, have opened new frontiers of research and development. …”
  19. 159
  20. 160